Jpmorgan Chase & Co »

Eyepoint Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $302k 21k 14.11
2026-03-31 $254k 21k 11.85
2024-03-31 $66k 3.2k 20.67
2023-12-31 $74k 3.2k 23.11

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Eyepoint Pharmaceuticals

Group One Trading
Rosalind Advisors
Simplex Trading
Jpmorgan Chase & Co

View all funds holding Eyepoint Pharmaceuticals